Needham initiated coverage on Inari Medical Inc (NASDAQ:NARI), noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient ...

The U.S. Food and Drug Administration cleared the FlowTriever catheter-based thrombectomy device in March. Now its maker, Inari Medical, has garnered a $12.4 million Series B round to continue to ...

Inari Medical has updated use instructions for its ClotTriever XL catheter after four injuries and six deaths were reported in association with the device. The ClotTriever XL is used for removing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Inari Medical Inc., a maker of medical devices to treat ...

The medical device maker boosted its revenue and returned to the black on net income. Management said it benefited from the launch of two new products. Inari focuses on devices that help treat venous ...

Inari Medical, Inc. (NASDAQ:NARI) is a medical device company that develops, manufactures, and markets devices for the interventional treatment of venous diseases. Its products primarily comprise ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other ...

Increased our position in Inari Medical, Inc. due to attractive valuations for a market-leading medical device company. Inari dominates the PE market and has significant growth opportunities in both ...

IRVINE, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...

Some of Inari’s clot-treating products; company says rising demand requires the need for a new, ‘high-volume manufacturing facility’ in Costa Rica Inari Medical Inc. (Nasdaq: NARI) is following the ...